journal article·2026-06-09Open access

Targeting Dnmt3a/m5C/RelA Axis Attenuates Microglia Inflammatory Response and Improves Postoperative Recovery in Chronic Compressive Cervical Spinal Cord Injury

Tianyu Qin, Yuan Jiang, Yongheng Xie, Huanwei Qu, Wenbin Yan, Jingle Chen, Yining Chen, Huayi Li, Naibo Feng, Jiajun Wu, Chao Zhang, Zhengqi Huang, Ming Shi, Zhihuai Deng, Guozhi Xiao, Houqing Long

Abstract

ABSTRACT Chronic compressive cervical spinal cord injury (cCSCI) is a major cause of adult spinal cord dysfunction. Surgical decompression is the primary treatment; however, microglia‐driven neuroinflammation often hampers postoperative recovery. This study was conducted to investigate the role of 5‐methylcytosine (m5C) in sustaining pro‐inflammatory microglial states following decompression. Using a mouse cCSCI model, we performed single‐nucleus RNA sequencing (snRNA‐seq) to map microglial states, calculated an m5C‐regulator activity score, and validated m5C changes via dot blot. We examined the Dnmt3a–RelA pathway in primary microglia through siRNA knockdown, m5C‐RIP, and mRNA stability assays. Therapeutic potential was assessed with intrathecal AAV‐shDnmt3a. SnRNA‐seq revealed a dominant pro‐inflammatory microglial subpopulation (C1) post‐decompression, enriched for NF‐κB signaling. The C1 subset exhibited an elevated m5C score and increased Dnmt3a expression. Dnmt3a knockdown reduced m5C enrichment on RelA transcripts, destabilized RelA mRNA, and suppressed NF‐κB activation. In vitro, Dnmt3a silencing reduced pro‐inflammatory marker expression and cytokine release, and microglia‐targeted AAV‐shDnmt3a improved neurological recovery in cCSCI mice. These findings underscore the potential of targeting the microglia Dnmt3a/m5C/RelA axis to enhance postoperative recovery.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Spinal Cord Injury Research · Neuroinflammation and Neurodegeneration Mechanisms · Cancer-related gene regulation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Division of Spine, Department of Orthopedics, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital Southern University of Science and Technology) Shenzhen China

Shenzhen Key Laboratory of Musculoskeletal Tissue Reconstruction and Function Restoration Shenzhen China

Division of Spine, Department of Orthopedics, Changde Hospital, Xiangya School of Medicine Central South University Changde China

Department of Orthopedics, Tianjin Hospital Tianjin University Tianjin China

Department of Trauma Orthopedics, Weifang People's Hospital Shandong Second Medical University Weifang China

Department of Orthopedics, Sun Yat‐sen Memorial Hospital Sun Yat‐sen University Guangzhou China

Department of Biochemistry Homeostatic Medicine Institute School of Medicine Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research Southern University of Science and Technology Shenzhen China

Guangdong Provincial Clinical Research Center for Geriatrics Shenzhen Clinical Research Center for Geriatrics Department of Geriatrics Shenzhen People's Hospital Shenzhen China

Funding

National Natural Science Foundation of China

References (50)

Show source-provided references
1. A New Dimension in Degenerative Cervical Myelopathy10.1016/S1474-4422(20)30454-3 ↗
2. Raising Awareness of Degenerative Cervical Myelopathy10.1016/S1474-4422(25)00074-2 ↗
3. Degenerative Cervical Myelopathy10.1136/bmj.k186 ↗
4. Traumatic Spinal Cord Injury10.1038/nrdp.2017.18 ↗
5. Degenerative Cervical Myelopathy — Update and Future Directions10.1038/s41582-019-0303-0 ↗
6. Toward A Personalized Approach: The Promising Horizon Of Degenerative Cervical Myelopathy10.1097/JS9.0000000000001569 ↗
7. The Influence of ApoE4 on the Clinical Outcomes and Pathophysiology of Degenerative Cervical Myelopathy10.1172/jci.insight.149227 ↗
8. Analysis of Recovery Trajectories in Degenerative Cervical Myelopathy to Facilitate Improved Patient Counseling and Individualized Treatment Recommendations
9. Blood‐spinal Cord Barrier Disruption in Degenerative Cervical Myelopathy10.1186/s12987-023-00463-y ↗
10. The Prevalence and Phenotype of Activated Microglia/Macrophages Within the Spinal Cord of the Hyperostotic Mouse (twy/twy) Changes in Response to Chronic Progressive Spinal Cord Compression: Implications for human Cervical Compressive Myelopathy10.1371/journal.pone.0064528 ↗
11. Inflammatory Cascades Mediate Synapse Elimination in Spinal Cord Compression10.1186/1742-2094-11-40 ↗
12. Long‐term Dynamics of the Spinal Cord Injury Neuroinflammatory Response and Sensory Dysfunction in Female Mice10.1016/j.bbi.2025.05.024 ↗
13. The Quiet Giant: Identification, Effectors, Molecular Mechanism, Physiological and Pathological Function in mRNA 5‐methylcytosine Modification10.7150/ijbs.101337 ↗
14. Biological Roles of RNA m5C Modification and Its Implications in Cancer Immunotherapy10.1186/s40364-022-00362-8 ↗
15. Detection, Molecular Function and Mechanisms of m5C in Cancer10.1002/ctm2.70239 ↗
16. The Prognostic Value and Immune Landscaps of m6A/m5C‐Related lncRNAs Signature in the Low Grade Glioma10.1186/s12859-023-05386-x ↗
17. Tetramethylpyrazine Promotes Functional Recovery After Spinal Cord Injury by Regulating 5‐Methylcytosine RNA Modification via the NSUN2‐XBP1 Axis10.1007/s12035-025-05520-1 ↗
18. Molecular Characterization and Clinical Characteristics of m5C‐Based RNA Methylation in Spinal Cord Injury: Validated by qPCR10.1155/2022/5433860 ↗
19. AGAPIR: A Novel PIWI‐Interacting RNA Enhancing Post‐Decompression Angiogenesis in Degenerative Cervical Myelopathy
20. Basso Mouse Scale for Locomotion Detects Differences in Recovery After Spinal Cord Injury in Five Common Mouse Strains10.1089/neu.2006.23.635 ↗
21. Fast, Sensitive and Accurate Integration of Single‐cell Data With Harmony10.1038/s41592-019-0619-0 ↗
22. clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters10.1089/omi.2011.0118 ↗
23. Reversed Graph Embedding Resolves Complex Single‐cell Trajectories10.1038/nmeth.4402 ↗
24. Impact of Microglia Isolation and Culture Methodology on Transcriptional Profile and Function10.1186/s12974-024-03076-w ↗
25. Rapid and Efficient Enrichment of Mouse Spinal Cord Microglia
26. DNA Methyltransferase 1 Modulates Mitochondrial Function Through Bridging m5C RNA Methylation10.1016/j.molcel.2025.04.019 ↗
27. Effectiveness of Surgical Decompression in Patients With Degenerative Cervical Myelopathy: Results of the Canadian Prospective Multicenter Study10.1093/neuros/nyab295 ↗
28. A Clinical Prediction Rule for Functional Outcomes in Patients Undergoing Surgery for Degenerative Cervical Myelopathy
29. Experimental Chronic Compressive Cervical Myelopathy: Effects of Decompression10.3171/jns.1995.83.2.0336 ↗
30. Blood Spinal Cord Barrier Disruption Recovers In Patients With Degenerative Cervical Myelopathy After Surgical Decompression: A Prospective Cohort Study10.1038/s41598-023-34004-2 ↗
31. Network Pharmacology Analysis and Animal Experiment Validation of Neuroinflammation Inhibition by Total Ginsenoside in Treating CSM10.1016/j.phymed.2023.155073 ↗
32. Mir21 Modulates Inflammation and Sensorimotor Deficits in Cervical Myelopathy: Data From Humans and Animal Models10.1093/braincomms/fcaa234 ↗
33. Targeting RelA/NLRP3/CCL3 Axis Mitigates Microglia Inflammatory Response and Promotes Recovery After Spinal Cord Injury10.1016/j.bbi.2025.07.015 ↗
34. TET1 mediated m5C Modification of RelB Aggravates Cerebral Ischemia/Reperfusion‐induced Neuroinflammation Through Regulating Microglia Polarization10.1016/j.cellsig.2024.111210 ↗
35. Cytosine Methylation of Mature microRNAs Inhibits Their Functions and Is Associated With Poor Prognosis in Glioblastoma Multiforme10.1186/s12943-020-01155-z ↗
36. m5C modification of mRNA Serves a DNA Damage Code to Promote Homologous Recombination10.1038/s41467-020-16722-7 ↗
37. The RNA m5C Modification in R‐loops as an off Switch of Alt‐NHEJ10.1038/s41467-023-41790-w ↗
38. Ultrafast Bisulfite Sequencing Detection of 5‐methylcytosine in DNA and RNA10.1038/s41587-023-02034-w ↗
39. CIGAR‐seq, a CRISPR/Cas‐based method for unbiased screening of novel mRNA modification regulators10.15252/msb.202010025 ↗
40. NF‐κB in Inflammation and Cancer10.1038/s41423-025-01310-w ↗
41. Modulation of Microglia Polarization Through Silencing of NF‐κB p65 by Functionalized Curdlan Nanoparticle‐Mediated RNAi10.1021/acsami.9b23004 ↗
42. DJ‐1 Inhibits Microglial Activation and Protects Dopaminergic Neurons In vitro and In vivo Through Interacting With Microglial p6510.1038/s41419-021-04002-1 ↗
43. Morin Regulates M1/M2 Microglial Polarization via NF‐κB p65 to Alleviate Vincristine‐Induced Neuropathic Pain10.2147/DDDT.S459757 ↗
44. Inflammation, Apoptosis and Autophagy as Critical Players in Vascular Dementia
45. SARS‐CoV‐2 Spike Promotes Inflammation and Apoptosis Through Autophagy by ROS‐suppressed PI3K/AKT/mTOR Signaling10.1016/j.bbadis.2021.166260 ↗
46. AO Spine Clinical Practice Recommendations for Diagnosis and Management of Degenerative Cervical Myelopathy: Evidence Based Decision Making—A Review of Cutting Edge Recent Literature Related to Degenerative Cervical Myelopathy10.1177/21925682251331050 ↗
47. Pharmacological Treatment of Degenerative Cervical Myelopathy: A Critical Review of Current Evidence10.14245/ns.2448140.070 ↗
48. Current Clinical Applications of In vivo Gene Therapy With AAVs10.1016/j.ymthe.2020.12.007 ↗
49. AAV Vectors Applied to the Treatment of CNS Disorders: Clinical Status and Challenges10.1016/j.jconrel.2023.01.067 ↗
50. Intrathecal Gene Therapy for Giant Axonal Neuropathy10.1056/NEJMoa2307952 ↗